Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

News SummaryMost relevantAll newsSector news 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

02/11/2013 | 10:44am US/Eastern
   By Melodie Warner 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
React to this article
11/24 REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Announce 18,000-Patient ODYSS..
11/23DJCVS Chooses New Cholesterol Drug for Caremark
11/23DJCVS Chooses Repatha as New Cholesterol Drug for Caremark
11/19 REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers, Financial..
11/16 REGENERON PHARMACEUTICALS : Entry into a Material Definitive Agreement (form 8-K..
11/13 REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
11/12 REGENERON PHARMACEUTICALS : Study Findings from Regeneron Pharmaceuticals Inc. B..
11/12 REGENERON PHARMACEUTICALS : Patent Issued for Stabilized Formulations Containing..
11/12 REGENERON PHARMACEUTICALS : Celebrates Patient Innovation and Growth in New York..
11/08 REGENERON PHARMACEUTICALS : and Sanofi Present Results from Pivotal Phase 3 Stud..
News chart
Full-screen chart
Income Statement Evolution
More Financials